US Patent Issued to LG CHEM on June 23 for "Pharmaceutically acceptable salt of sphingosine-1-phosphate receptor agonist, and crystalline form thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,349, issued on June 23, was assigned to LG CHEM Ltd. (Seoul, South Korea).

"Pharmaceutically acceptable salt of sphingosine-1-phosphate receptor agonist, and crystalline form thereof" was invented by Seul Ah Chun (Seoul, South Korea), Sung Wook Kim (Seoul, South Korea), Ji Yoon Kim (Seoul, South Korea), Sung Won Kim (Seoul, South Korea) and Ki Sook Park (Cheongju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutically acceptable salt of a sphingosine-1-phosphate receptor agonist and a crystalline form thereof, and more specifically, to a potassium salt or methanesulfonate of 1-[1-chloro-6-(3...